What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks

Overview


Robert (Bob) H. Cohen will speak on McDermott Will & Emery and BDO’s co-hosted program, “What’s Next for SPACs in the Life Sciences Industry? A Discussion with Ginkgo Bioworks.”

With over 200 special purpose acquisition company (SPAC) IPOs and over 100 SPAC mergers and counting over the last year, SPACs are hotter than ever. But are they the right approach for most Life Sciences companies seeking capital?

Join BDO and McDermott Will & Emery for a discussion with Anna Marie Wagner, Senior Vice President, Corporate Development of Ginkgo Bioworks, around SPACs in the Life Sciences industry.

We’ll discuss:

  • How to evaluate whether a SPAC is the right capital raising vehicle
  • How the new administration has affected the SPAC market
  • Accounting considerations that can potentially derail valuation
  • How to mitigate risks and challenges associated with a SPAC deal

Dig Deeper

Webinar / American Conference Institutes (ACI) / September 29-30, 2021

ACI's FDA Boot Camp

Webinar / Momentum Events / September 13-14, 2021

Momentum Events: Strategy Summit on Paragraph IV Litigation

Two Day Virtual Event / McDermott Event / June 23-24, 2021

HPE Europe 2021

Webinar / FDLI / June 16, 2021

The Essentials of Clinical Trial Science